⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABL News
Abacus Global Management, Inc. Class A Common Stock
CD137 Targeted Therapy Research Report 2026-2030: Market Opportunities, Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights - ResearchAndMarkets.com
businesswire.com
GMAB
ABL
BNTX
BCRX
CD137 Targeted Therapy Research Report 2026-2030: 90 Therapies in Clinical Trials, Upcoming Commercial Launches, Global & Regional Clinical & Commercial Trends,
globenewswire.com
GILD
BMY
REGN
MRK
GENM
ABL
BNTX
BIIB
CD137 Targeted Therapy Research Report 2026-2030: 90 Therapies in Clinical Trials, Upcoming Commercial Launches, Global & Regional Clinical & Commercial Trends,
globenewswire.com
GILD
BMY
REGN
MRK
PFE
ABBV
BIIB
AZN
AMGN
NVS
GMAB
ABL
BNTX
ABX Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm
prnewswire.com
ABX
ABL
ABX Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm
globenewswire.com
ABX
ABL
Ascend Advanced Therapies – ABL Inc. verstärkt sein Führungsteam weiter, um seine ambitionierte Wachstumsstrategie voranzutreiben
accessnewswire.com
ABL
ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm
globenewswire.com
ABL
ABX
ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm
businesswire.com
ABL
Abacus Global Management Announces Transfer of Listing of its [Class A] Common Stock to the New York Stock Exchange with New Ticker Symbol “ABX”
globenewswire.com
ABL
Sidoti Events, LLC's Year-End Virtual Investor Conference
accessnewswire.com
CRGO
NNOX
WDH
ICFI
FSTR
MNY
VPG
PRE
CRAI
IHRT
OIS
GRC
DRTS
KOP
FFAI
GAIA
ROCK
MTRX
ACIC
MG
CIA
MEHA
SINT
BODI
BAER
OPRT
COE
GATX
KELYA
PANL
PAR
PLXS
UIS
EVAX
DTIL
OWLS
LRE
USNA
IRIX
LZM
CNXN
FIX
XBP
STRT
FBIZ
MPTI
TOMZ
ABL
SBC
HRTG
CRDF
INV
RAIL
MGRC
OSPN
SRTA
SRTAW